Ignite Creation Date:
2025-12-24 @ 11:41 PM
Ignite Modification Date:
2026-02-18 @ 5:23 PM
Study NCT ID:
NCT01894451
Status:
COMPLETED
Last Update Posted:
2019-12-12
First Post:
2013-06-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative Chemotherapy
Sponsor:
Dana-Farber Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-06
Start Date Type:
ACTUAL
Primary Completion Date:
2017-03-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-03-17
Completion Date Type:
ACTUAL
First Submit Date:
2013-06-25
First Submit QC Date:
None
Study First Post Date:
2013-07-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-12-10
Last Update Post Date:
2019-12-12
Last Update Post Date Type:
ACTUAL